BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36988385)

  • 21. Nonhypervascular Hypointense Nodules at Gadoxetic Acid-enhanced MR Imaging in Chronic Liver Disease: Diffusion-weighted Imaging for Characterization.
    Hwang J; Kim YK; Jeong WK; Choi D; Rhim H; Lee WJ
    Radiology; 2015 Jul; 276(1):137-46. PubMed ID: 25734551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of gadoxetic acid-enhanced and diffusion-weighted MR imaging in evaluation of hepatocellular carcinomas with atypical enhancement pattern on contrast-enhanced multiphasic MDCT in patients with chronic liver disease.
    Kim HS; Kim SH; Kang TW; Song KD; Choi D; Park CK
    Eur J Radiol; 2015 Apr; 84(4):555-62. PubMed ID: 25617950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images.
    Kang Y; Lee JM; Kim SH; Han JK; Choi BI
    Radiology; 2012 Sep; 264(3):751-60. PubMed ID: 22798225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.
    Kim R; Lee JM; Shin CI; Lee ES; Yoon JH; Joo I; Kim SH; Hwang I; Han JK; Choi BI
    Eur Radiol; 2016 Jun; 26(6):1808-17. PubMed ID: 26373763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Washout appearance in Gd-EOB-DTPA-enhanced MR imaging: A differentiating feature between hepatocellular carcinoma with paradoxical uptake on the hepatobiliary phase and focal nodular hyperplasia-like nodules.
    Kim JW; Lee CH; Kim SB; Park BN; Park YS; Lee J; Park CM
    J Magn Reson Imaging; 2017 Jun; 45(6):1599-1608. PubMed ID: 27726242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.
    Jang KM; Kim SH; Kim YK; Choi D
    Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging features of fibrolamellar hepatocellular carcinoma in gadoxetic acid-enhanced MRI.
    Palm V; Sheng R; Mayer P; Weiss KH; Springfeld C; Mehrabi A; Longerich T; Berger AK; Kauczor HU; Weber TF
    Cancer Imaging; 2018 Mar; 18(1):9. PubMed ID: 29490696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psoriatic arthritis associated with peliosis hepatis: characteristics and therapeutic management.
    Slouma M; Khrifech Y; Dhahri R; Hannech E; Tayeb Z; Ghozzi A; Metoui L; Gharsallah I; Louzir B
    Clin Rheumatol; 2021 Sep; 40(9):3827-3832. PubMed ID: 33598810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peliosis hepatis: 2 case reports of a rare liver disorder and its differential diagnosis.
    Dai YN; Ren ZZ; Song WY; Huang HJ; Yang DH; Wang MS; Huang YC; Chen MJ; Zhang JJ; Tong YX; Pan HY
    Medicine (Baltimore); 2017 Mar; 96(13):e6471. PubMed ID: 28353584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A New Reporting System for Diagnosis of Hepatocellular Carcinoma in Chronic Hepatitis B With Clinical and Gadoxetic Acid-Enhanced MRI Features.
    Hwang SH; Hong SB; Han K; Seo N; Choi JY; Lee JH; Park S; Lim YS; Kim DY; Kim SY; Park MS
    J Magn Reson Imaging; 2022 Jun; 55(6):1877-1886. PubMed ID: 34668595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lesion detection performance of an abbreviated gadoxetic acid-enhanced MRI protocol for colorectal liver metastasis surveillance.
    Canellas R; Patel MJ; Agarwal S; Sahani DV
    Eur Radiol; 2019 Nov; 29(11):5852-5860. PubMed ID: 30888485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinction Between Hepatocellular Carcinoma and Hypervascular Liver Metastases in Non-cirrhotic Patients Using Gadoxetate Disodium-Enhanced Magnetic Resonance Imaging.
    Ichikawa S; Morisaka H; Omiya Y; Onishi H
    Can Assoc Radiol J; 2022 Nov; 73(4):639-646. PubMed ID: 35341349
    [No Abstract]   [Full Text] [Related]  

  • 33. Small (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging.
    Yu MH; Kim JH; Yoon JH; Kim HC; Chung JW; Han JK; Choi BI
    Radiology; 2014 Jun; 271(3):748-60. PubMed ID: 24588677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Added value of smooth hypointense rim in the hepatobiliary phase of gadoxetic acid-enhanced MRI in identifying tumour capsule and diagnosing hepatocellular carcinoma.
    An C; Rhee H; Han K; Choi JY; Park YN; Park MS; Kim MJ; Park S
    Eur Radiol; 2017 Jun; 27(6):2610-2618. PubMed ID: 27770230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperintense nodule-in-nodule on hepatobiliary phase arising within hypovascular hypointense nodule: Outcome and rate of hypervascular transformation.
    Cannella R; Calandra A; Cabibbo G; Midiri M; Tang A; Brancatelli G
    Eur J Radiol; 2019 Nov; 120():108689. PubMed ID: 31563835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multifocal peliosis hepatis: MR and diffusion-weighted MR-imaging findings of an atypical case.
    Battal B; Kocaoglu M; Atay AA; Bulakbasi N
    Ups J Med Sci; 2010 May; 115(2):153-6. PubMed ID: 20095924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Triple-Classification Radiomics Model for the Differentiation of Primary Chordoma, Giant Cell Tumor, and Metastatic Tumor of Sacrum Based on T2-Weighted and Contrast-Enhanced T1-Weighted MRI.
    Yin P; Mao N; Zhao C; Wu J; Chen L; Hong N
    J Magn Reson Imaging; 2019 Mar; 49(3):752-759. PubMed ID: 30430686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemorrhagic necrosis due to peliosis hepatis: imaging findings and pathological correlation.
    Vignaux O; Legmann P; de Pinieux G; Chaussade S; Spaulding C; Couturier D; Bonnin A
    Eur Radiol; 1999; 9(3):454-6. PubMed ID: 10087115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MR imaging features for improved diagnosis of hepatocellular carcinoma in the non-cirrhotic liver: Multi-center evaluation.
    Fischer MA; Raptis DA; Donati OF; Hunziker R; Schade E; Sotiropoulos GC; McCall J; Bartlett A; Bachellier P; Frilling A; Breitenstein S; Clavien PA; Alkadhi H; Patak MA
    Eur J Radiol; 2015 Oct; 84(10):1879-87. PubMed ID: 26194029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging.
    Kim JE; Kim SH; Lee SJ; Rhim H
    AJR Am J Roentgenol; 2011 Jun; 196(6):W758-65. PubMed ID: 21606265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.